SRSA
S.R. Schill & Associates’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,345
| Closed | -$574K | – | 40 |
|
|
2024
Q2 | $574K | Sell |
3,345
-2,718
| -45% | -$466K | 0.25% | 40 |
|
|
2024
Q1 | $1.1M | Sell |
6,063
-305
| -5% | -$55.5K | 0.48% | 28 |
|
|
2023
Q4 | $987K | Sell |
6,368
-3
| -0% | -$465 | 0.44% | 28 |
|
|
2023
Q3 | $950K | Hold |
6,371
| – | – | 0.46% | 25 |
|
|
2023
Q2 | $858K | Hold |
6,371
| – | – | 0.39% | 26 |
|
|
2023
Q1 | $1.02M | Hold |
6,371
| – | – | 0.47% | 24 |
|
|
2022
Q4 | $1.03M | Sell |
6,371
-148
| -2% | -$23.9K | 0.51% | 25 |
|
|
2022
Q3 | $875K | Buy |
6,519
+1,355
| +26% | +$182K | 0.47% | 25 |
|
|
2022
Q2 | $791K | Hold |
5,164
| – | – | 0.4% | 26 |
|
|
2022
Q1 | $837K | Sell |
5,164
-2,129
| -29% | -$345K | 0.35% | 28 |
|
|
2021
Q4 | $987K | Sell |
7,293
-978
| -12% | -$132K | 0.39% | 27 |
|
|
2021
Q3 | $892K | Buy |
8,271
+215
| +3% | +$23.2K | 0.38% | 31 |
|
|
2021
Q2 | $907K | Hold |
8,056
| – | – | 0.36% | 34 |
|
|
2021
Q1 | $872K | Buy |
8,056
+250
| +3% | +$27.1K | 0.38% | 36 |
|
|
2020
Q4 | $836K | Sell |
7,806
-675
| -8% | -$72.3K | 0.39% | 31 |
|
|
2020
Q3 | $743K | Buy |
8,481
+1,919
| +29% | +$168K | 0.38% | 32 |
|
|
2020
Q2 | $644K | Buy |
6,562
+2,828
| +76% | +$278K | 0.38% | 36 |
|
|
2020
Q1 | $284K | Sell |
3,734
-17
| -0.5% | -$1.29K | 0.19% | 55 |
|
|
2019
Q4 | $332K | Buy |
3,751
+490
| +15% | +$43.4K | 0.18% | 68 |
|
|
2019
Q3 | $247K | Buy |
3,261
+347
| +12% | +$26.3K | 0.14% | 69 |
|
|
2019
Q2 | $212K | Hold |
2,914
| – | – | 0.13% | 73 |
|
|
2019
Q1 | $235K | Hold |
2,914
| – | – | 0.14% | 72 |
|
|
2018
Q4 | $269K | Hold |
2,914
| – | – | 0.19% | 68 |
|
|
2018
Q3 | $276K | Buy |
2,914
+750
| +35% | +$71K | 0.17% | 73 |
|
|
2018
Q2 | $200K | Buy |
+2,164
| New | +$200K | 0.12% | 78 |
|